Repligen (RGEN) Restructuring Costs (2012 - 2026)
Repligen's (RGEN) quarterly Restructuring Costs came in at $2.7 million in Q2 2026, up 25.72% year-over-year from $2.2 million in Q2 2025, and up 81.68% quarter-over-quarter from $1.5 million in Q1 2026.
Analysis
Repligen (RGEN) Restructuring Costs (2012 - 2026) Analysis & Trends
Repligen (RGEN) has reported Restructuring Costs for 5 consecutive years, with $2.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Restructuring Costs rose 25.72% year-over-year to $2.7 million in Q2 2026; TTM through Jun 2026 was $8.3 million, a 37.09% increase from a year earlier, with the FY2014 full-year figure at $1.9 million, up 2032.89% from the prior year.
- Restructuring Costs was $2.7 million for Q2 2026 at Repligen, up from $1.5 million in the prior quarter.
- Over five years, Restructuring Costs peaked at $2.7 million in Q2 2026 and troughed at $1.5 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.72 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Jun 30, 2025 | 2.16 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2014 | 1.95 Mn |
| Sep 30, 2014 | 10,000.00 |
| Jun 30, 2014 | 18,000.00 |
| Mar 31, 2014 | 98,000.00 |
| Dec 31, 2013 | 45,000.00 |
| Sep 30, 2013 | 65,000.00 |
| Jun 30, 2013 | 35,000.00 |
| Mar 31, 2013 | -54,000.00 |
| Dec 31, 2012 | 267,000.00 |
| Sep 30, 2012 | 344,000.00 |